Zobrazeno 101 - 110
of 208
pro vyhledávání: '"Andrew Haydon"'
Autor:
Mark Nelson, Peter Gibbs, Andrew Haydon, Christopher M. Reid, Brenda Kirpach, Jessica E. Lockery, Robyn L. Woods, John J McNeil, Rory Wolfe, Suzanne G Orchard, Anne M. Murray, Galina Polekhina, John Zalcberg
Publikováno v:
Contemp Clin Trials
BACKGROUND: Cancer is a leading cause of death globally. Given the elevated risk of cancer with age and an ageing population, it is important to understand the changing burden of cancer in older populations. The ASPirin in Reducing Events in the Elde
Autor:
Andrew Haydon
Publikováno v:
Theatre Criticism. :135-152
Autor:
Jacqui Adams, M.M.K. Chan, Ray Asghari, Xanthi Coskinas, Karen Briscoe, Michael Millward, Theresa Hayes, A. Davidson, A. Tognela, Matthew T. V. Chan, Susan Tiley, Nick Muljadi, Vy. Broaddge, Catherine Crombie, Mohammed Islam, N. Pavlakis, Ray M. Lowenthal, Andrew Davidson, Rasha Cosman, X. Coskinas, M.R. Stockler, C. Crombie, Robert Blum, Craig R. Lewis, C.R. Lewis, Nick Pavlakis, Adam Boyce, S. Begbie, Martin R. Stockler, Stephen Begbie, David Gibbs, Michael Boyer, Annette Tognela, Steven Ackland, Sue-Anne McLachlan, David Espinoza, Andrew Haydon, E Abdi, B.G.M. Hughes, Girish Mallesara, Jeremy Long, Janette L. Vardy, Adam Broad, J. Long, Kevin Jasas, N. Muljadi, A. Broad, Suresh Vama, S. Chinchen, Victoria J Bray, Anne-Sophie Veillard, S. Varma, M. Boyer, K. Briscoe, E. Abdi, A. Boyce, Brett G.M. Hughes, Sarah Chinchen, Danielle Ferraro
Publikováno v:
Annals of Oncology. 26:2280-2286
Background We sought to determine whether the substantial benefits of topical nitroglycerin with first-line, platinum-based, doublet chemotherapy in advanced nonsmall-cell lung cancer (NSCLC) seen in a phase II trial could be corroborated in a rigoro
Autor:
Andrew Haydon, Hayley N. Roberts
Publikováno v:
Annals of Translational Medicine. 8:720-720
Autor:
Shahneen Sandhu, Patrick A. Ott, Céleste Lebbé, Douglas B. Johnson, Matteo S. Carlino, Alison Weppler, Lauren Julia Brown, Clara Allayous, Alexander M. Menzies, Andrew Haydon, James R. Patrinely, Georgina V. Long, Prachi Bhave
Publikováno v:
Journal of Clinical Oncology. 38:10026-10026
10026 Background: Clinical trials of immunotherapy exclude patients (pts) with pre-existing AD. While retrospective data exist regarding the efficacy and safety of single agent ipi and anti-PD1 antibodies (PD1) in pts with AD, no data are available r
Autor:
Andrew Haydon, Marta Nyakas, James Larkin, Richard F. Kefford, Reinhard Dummer, Egbert de Jong, Dirk Schadendorf, V. Chiarion-Sileni, Caroline Robert, Christine-Elke Ortmann, John M. Kirkwood, Axel Hauschild, Victoria Atkinson, Mario Santinami, Caroline Dutriaux, Edward Gasal, Georgina V. Long, Mario Mandalà, Jacob Schachter, Laurent Mortier
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 3:S53
not available.
Publikováno v:
Melanoma Management
There is a global increase in the incidence of melanoma, with approximately 300,000 new cases in 2018 worldwide, according to statistics from the International Agency for Research on Cancer. With this rising incidence, it is important to optimize tre
Autor:
Rachel Ward, Mark Voskoboynik, Jeremy D Ruben, Robin E. Smith, M. van Zelm, Simone Reinwald, Andrew Haydon, Sashendra Senthi, Di Yu, Mark Shackleton, Gishan Ratnayake
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:S61
Autor:
Michele Maio, Karl Lewis, Lev Demidov, Mario Mandalà, Igor Bondarenko, Paolo A Ascierto, Christopher Herbert, Andrzej Mackiewicz, Piotr Rutkowski, Alexander Guminski, Grant R Goodman, Brian Simmons, Chenglin Ye, Yibing Yan, Dirk Schadendorf, Gabriela Cinat, Luis Enrique Fein, Michael Brown, Andrew Haydon, Adnan Khattak, Catriona McNeil, Phillip Parente, Jeremy Power, Rachel Roberts-Thomson, Shahneen Sandhu, Craig Underhill, Suresh Varma, Thomas Berger, Ahmad Awada, Nathalie Blockx, Veronique Buyse, Jeroen Mebis, Fábio André Franke, Sérgio Jobim de Azevedo, Nicolas Silva Lazaretti, Rahima Jamal, Catalin Mihalcioiu, Teresa Petrella, Kerry Savage, Xinni Song, Ralph Wong, Nina Dabelic, Stjepko Plestina, Zeljko Vojnovic, Petr Arenberger, Ivo Kocak, Ivana Krajsova, Eugen Kubala, Bohuslav Melichar, Yvetta Vantuchova, Kadri Putnik, Brigitte Dreno, Caroline Dutriaux, Jean-Jacques Grob, Pascal Joly, Jean-Philippe Lacour, Nicolas Meyer, Laurent Mortier, Luc Thomas, Michael Fluck, Thilo Gambichler, Jessica Hassel, Axel Hauschild, Paul Donnellan, John McCaffrey, Derek Power, Samuel Ariad, Gil Bar-Sela, Daniel Hendler, Ilan Ron, Jacob Schachter, Paolo Ascierto, Alfredo Berruti, Luca Bianchi, Vanna Chiarion Sileni, Francesco Cognetti, Riccardo Danielli, Anna Maria Di Giacomo, Luca Gianni, Aron Goldhirsch, Michele Guida, Paolo Marchetti, Paola Queirolo, Armando Santoro, Ellen Kapiteijn, Paula Ferreira, Georgy Gafton, Yulia Makarova, Zoran Andric, Nada Babovic, Darjana Jovanovic, Lidija Kandolf Sekulovic, Graham Cohen, Lydia Dreosti, Daniel Vorobiof, Maria Teresa Curiel Garcia, Roberto Diaz Beveridge, Margarita Majem Tarruella, Ivan Marquez Rodas, Jose-M Puliats Rodriguez, Antonio Rueda Dominguez, Marianne Maroti, Karin Papworth, Olivier Michielin, Ewan Brown, Pippa Corrie, Mark Harries, Satish Kumar, Agustin Martin-Clavijo, Mark Middleton, Poulam Patel, Toby Talbot, Sanjiv Agarwala, Paul Chapman, Robert Conry, Gary Doolittle, Tara Gangadhar, Sigrun Hallmeyer, Omid Hamid, Leonel Hernandez-Aya, Douglas Johnson, Frederic Kass, Tatjana Kolevska, Scott Lunin, April Salama, Branimir Sikic, Bradley Somer, David Spigel, Eric Whitman
Summary Background Systemic adjuvant treatment might mitigate the high risk of disease recurrence in patients with resected stage IIC–III melanoma. The BRIM8 study evaluated adjuvant vemurafenib monotherapy in patients with resected, BRAF V600 muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ca377ad3c682462789b57095f06c16
http://hdl.handle.net/11379/501841
http://hdl.handle.net/11379/501841
Autor:
John M. Kirkwood, Jacob Schachter, Mario Mandalà, Mario Santinami, C. Dutriaux, C. Robert, X. Feng, Dirk Schadendorf, E. de Jong, Laurent Mortier, Andrew Haydon, James Larkin, Richard F. Kefford, Georgina V. Long, Victoria Atkinson, Bijoyesh Mookerjee, Marta Nyakas, Axel Hauschild, V. Chiarion Sileni, Reinhard Dummer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f41d21e3764699e1e84acfa666015a8
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85077771000
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85077771000